Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections
- 30 June 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 20 (6) , 1083-1087
- https://doi.org/10.1016/s0190-9622(89)70137-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1987
- Topical Mupirocin Versus Oral Erythromycin in the Treatment of Primary and Secondary Skin InfectionsInternational Journal of Dermatology, 1987
- Predominance of certain klebsiella capsular typesin hospitals in the United KingdomJournal of Infection, 1979
- Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Echerichia coli by pseudomonic acidBiochemical Journal, 1978
- On the mode of action of pseudomonic acid: Inhibition of protein synthesis in Staphylococcus aureus.The Journal of Antibiotics, 1978
- GENTAMICIN-RESISTANT KLEBSIELLA AEROGENES IN A UROLOGICAL WARDThe Lancet, 1977
- Gentamicin resistant Staphylococcus aureus associated with the use of topical gentamicinJournal of Antimicrobial Chemotherapy, 1977
- Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards.Journal of Clinical Pathology, 1977
- Epidemiology of Contact Dermatitis in North America: 1972Archives of Dermatology, 1973
- Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescensNature, 1971